#Obesity #GLP1 #BehaviouralMedicine #dietetics To view or add a comment, sign in New consensus statement, out this week in The Lancet Diabetes & Endocrinology, from European Association for the Study of Obesity (EASO), The European Federation of the Associations of Dietitians (EFAD) and ECPObesity: "Nutritional, functional, and psychological considerations for incretin-based therapies in adults." Link in comments
Can tesamorelin be combined with other peptides
However, at Blue Horizon, we encourage you to look at the trends
HSA and FSA: what qualifies Health Savings Accounts and Flexible Spending Accounts may be used for peptide therapy when the treatment is prescribed for a documented medical condition by a licensed provider
Coverage for anti-obesity medications, particularly GLP-1 agonists, varies significantly by insurer and plan
It was, like, I dont even want to get high! I was struck by how much her description echoed what Mary and Susan had told me